Darrell & King’s Zimmer Biomet ZBH Stock Holding History

Darrell & King’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,679	Closed	-$208K	–	55
2019 Q1	$208K	Buy	+1,679	New	+$191K	0.03%	49
2017 Q1	–	Sell	-175,257	Closed	-$17.6M	–	52
2016 Q4	$17.6M	Buy	175,257 +97	+0.1%	+$10.4K	2.84%	19
2016 Q3	$22.1M	Sell	175,160 -5,451	-3%	-$673K	3.81%	19
2016 Q2	$21.1M	Sell	180,611 -4,217	-2%	-$477K	3.95%	16
2016 Q1	$19.1M	Buy	184,828 +860	+0.5%	+$83.2K	3.62%	17
2015 Q4	$18.3M	Buy	+183,968	New	+$18M	3.06%	20

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Darrell & King's ZBH Position: Q2 2019 in Review

Darrell & King sold out of Zimmer Biomet (ZBH) in Q2 2019, closing a stake of 1,679 shares — an estimated $208K sold.

Darrell & King first reported a position in ZBH in Q4 2015 and held it in 6 quarters. The position peaked at $22.1M in Q3 2016. 883 funds tracked by Wall St. Rank hold ZBH as of Q2 2019.

Darrell & King reported no remaining Zimmer Biomet position as of Q2 2019 after selling out during the quarter.
Darrell & King sold 1,679 Zimmer Biomet shares in Q2 2019, an estimated $208K.
Darrell & King first reported a position in Zimmer Biomet in Q4 2015 and held it in 6 quarters.
Darrell & King's Zimmer Biomet position peaked at $22.1M in Q3 2016.
883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2019.

Based on Darrell & King's 13F filing for Q2 2019, filed 15 Aug 2019.